|
Basic InformationMore InformationLatest NewsHIV No Barrier to Getting Liver Transplant, Study FindsXofigo Approved for Prostate CancerTest Approved to Detect Faulty Lung Cancer GeneNew Drug May Help Immune System Fight CancerCancer Patients May Face Higher Bankruptcy OddsFDA Approves New Drug to Fight Advanced Prostate CancerMetformin Won't Aid Breast Cancer Survival in DiabeticsCreative Arts Therapies Up Mental Health for Cancer PatientsExperts Aim to Draw Attention to High Cancer Drug CostsCreative Arts May Help Cancer Patients CopeAgent Orange Tied to Lethal Prostate CancerScientists Discover More Genetic Clues to Testicular CancerSocializing May Ease Pain of Breast CancerGene Discovery May Offer Breakthrough for Rare LeukemiaRed Hair Pigment Might Raise Melanoma Risk: StudySkin Cancer Tx Mostly Surgical, Regardless of Life ExpectancyAATS: MnDCT Beats Chest X-Ray for Detecting Lung CancerProstate Cancer May Be Deadlier for the UninsuredSleep Woes Tied to Prostate Cancer Risk in StudyAUA: Incidence of Testicular Cancer Up Through 2009Study Links Timing of ER Visit to Prostate Cancer Survival OddsTesticular Cancer on Rise in U.S., Especially Among Hispanic MenUrologists' Group Issues Updated Guidelines on PSA TestAt-Home Drug Errors Common for Kids With Cancer, Research ShowsScientists Pinpoint Most Major Genes Behind Deadly Blood CancerImplants May Delay Breast Cancer Detection, Raise Death RiskComprehensive Analysis Supports SERMs for Cutting Breast CancerNovel System Proposed for Accountable Cancer CareWomen Smokers More Likely to Get Colon Cancer Than Men: StudyFor Some Seniors With Skin Cancer, Surgery Not Always Best ChoiceComprehensive Discussion With Docs Ups Cancer ScreeningHistory of Skin Cancer Linked to Secondary CancersIntegrated 2D, 3D Mammogram Improves Cancer DetectionSoaring Prices Keep Leukemia Drugs From Patients, Experts SayRace, Income Tied to Breast Cancer Treatment Delays, Reduced SurvivalObesity Tied to Risk of Prostate Cancer After Negative BiopsyNon-Melanoma Skin Cancers Tied to Risk for Other CancersObesity Linked to Prostate Cancer, Study FindsMammograms Can Measure How Breast Cancer Drug Is Working: StudyScientists Spot Cancer Metabolism ChangesMinorities Less Prone to Think They'll Get Cancer: StudyClinical Trials Helped One Woman's Fight Against CancerARRS: MASS Criteria, LDH Predict Survival in MelanomaScientists Create Breast Cancer Survival PredictorEndocrine Therapy Often Incomplete after Breast CancerEndometriosis Surgery Linked to Lower Ovarian Cancer RiskReview Suggests Breast Cancer Screens Should Be PersonalizedMenopause-Like Woes Hinder Breast Cancer Treatment: StudySmoking Raises Asbestos Workers' Cancer Risk, Study SaysGene May Boost Death Risk From Most Common Thyroid Cancer LinksBook Reviews |
| |
New Guidelines Issued for Biopsy Use in Melanoma Patients
by -- Mary Elizabeth Dallas
Updated: Jul 9th 2012
MONDAY, July 9 (HealthDay News) -- Sentinel lymph node biopsy -- a minimally invasive surgical technique that lets doctors see whether cancer has spread -- should be performed on patients with melanoma tumors of intermediate thickness and may also be appropriate for thick melanoma tumors, according to new guidelines released Monday.
The American Society of Clinical Oncology (ASCO) and the Society for Surgical Oncology issued the evidence-based recommendations to clarify the use of this type of biopsy, which they said has been inconsistent.
A sentinel lymph node is the first lymph node to which cancer cells are most likely to spread from the original tumor, according to the U.S. National Cancer Institute. There can be more than one sentinel lymph node. During a biopsy, the node is identified, removed and examined for cancer cells.
"When used for the right patients at the right time, sentinel lymph node biopsy is one of our best tools for personalizing melanoma treatment, and for sparing patients from unnecessary procedures or therapies," study lead author Dr. Sandra Wong, co-chair of the guideline panel and an assistant professor of surgery at the University of Michigan, said in an ASCO news release.
The panel of 14 clinical and methodological experts from various disciplines reviewed 73 studies, involving 25,000 patients, that were published over the past two decades. After examining this evidence, the panel made the following recommendations:
- The procedure is recommended for all patients with melanoma tumors between 1 millimeter (mm) and 4 mm (intermediate thickness). Sentinel lymph node biopsy detects cancer in the sentinel node in about 18 percent to 26 percent of these patients, the panel noted.
- Sentinel lymph node biopsy may be beneficial to patients with melanoma tumors greater than 4 mm ("thick"). The panel noted, however, that few studies focus on the use of the biopsy in patients with thick melanomas.
- The panel found there is not enough evidence to recommend routine sentinel lymph node biopsy for patients with melanoma tumors less than 1 mm ("thin"). The experts added that thin melanomas can usually be cured through surgical removal of the primary tumor. However, the biopsy could be considered in patients with thin melanoma who have certain high-risk factors, such as rapidly dividing cancer cells.
Patients with a positive sentinel lymph node biopsy should undergo complete removal of the remaining lymph nodes, the experts added. This procedure has been shown to prevent the spread of cancer.
The panel also advised doctors to discuss sentinel lymph node biopsy, particularly the procedure's potential risks and benefits, with their patients as part of the treatment-planning process.
"Our rapidly growing understanding of the biology of melanoma is driving development of more effective treatments with fewer side effects for patients," panel co-chair Dr. Gary Lyman, a professor of medicine and director of comparative effectiveness and outcomes research at Duke University School of Medicine and the Duke Cancer Institute, said in the news release.
"But to take advantage of this progress, we need to know the true extent of the disease from the start. This guideline will help ensure that sentinel lymph node biopsy is used appropriately whenever it can provide that vital information while avoiding unnecessary procedures in patients who are unlikely to benefit."
Information on the guidelines was published online by ASCO.
More information
The U.S. National Cancer Institute has more about melanoma.
This article: Copyright © 2012 HealthDay. All rights reserved. |